ExcellGene - Model SARS-CoV-2 - Stabilized Omicron Trimeric Spike Protein for Omicron Variant

The SARS-CoV-2 Omicron variant became known to the general public recently (end of November 2021) and is characterized by many mutations in the Spike protein and other regions of the virus genome. It seems to spread even more rapidly than the Delta variant, and questions about the protection against this variant by presently used vaccines have been raised. This variant may have an increased capacity to re-infect vaccinated people.